This scientific symposium was designed for nephrologists and other healthcare professionals to discuss on the clinical experience of ATLG and address the issues pertaining to HCV infection before and after kidney transplant.
Prof. Nassim Kamar
Professor in Nephrology Centre hospitalier universitaire (CHU) de Toulouse Toulouse, France